Results 211 to 220 of about 792,259 (266)
Methyltransferase-Like 3-Mediated N<sup>6</sup>-Methyladenosine Modification on RNAs: A Novel Perspective for the Pathogenesis and Treatment of Bone Diseases. [PDF]
Xiao D, Zhang D, Qu Y, Su X.
europepmc +1 more source
Integrating deep phenotyping with genetic analysis: a comprehensive workflow for diagnosis and management of rare bone diseases. [PDF]
Li G +12 more
europepmc +1 more source
Development of Hybrid Implantable Local Release Systems Based on PLGA Nanoparticles with Applications in Bone Diseases. [PDF]
Ciocîlteu MV +10 more
europepmc +1 more source
Retracted: Exosome: Function and Application in Inflammatory Bone Diseases. [PDF]
Longevity OMAC.
europepmc +1 more source
Use of Complementary and Alternative Medicine in Patients with Rare Bone Diseases and Osteoporosis. [PDF]
Kocijan R +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Endocrinology and Metabolism Clinics of North America, 2015
Pituitary hormones have direct and indirect effects on bone remodeling, and skeletal fragility is a frequent complication of pituitary diseases. Fragility fractures may occur in many patients with prolactinomas, acromegaly, Cushing disease, and hypopituitarism.
MAZZIOTTI, Gherardo +2 more
openaire +4 more sources
Pituitary hormones have direct and indirect effects on bone remodeling, and skeletal fragility is a frequent complication of pituitary diseases. Fragility fractures may occur in many patients with prolactinomas, acromegaly, Cushing disease, and hypopituitarism.
MAZZIOTTI, Gherardo +2 more
openaire +4 more sources
Calcified Tissue International, 2019
Paget's disease of bone (PDB) is a chronic and focal bone disorder, characterized by increased osteoclast-mediated bone resorption and a subsequent compensatory increase in bone formation, resulting in a disorganized mosaic of woven and lamellar bone at one or more affected skeletal sites.
Luigi Gennari +3 more
openaire +5 more sources
Paget's disease of bone (PDB) is a chronic and focal bone disorder, characterized by increased osteoclast-mediated bone resorption and a subsequent compensatory increase in bone formation, resulting in a disorganized mosaic of woven and lamellar bone at one or more affected skeletal sites.
Luigi Gennari +3 more
openaire +5 more sources
Bone changes in metabolic bone disease
Acta Orthopaedica Scandinavica, 1995In order to secure the mechanical integrity of the skeleton bone undergoes constant renewal throughout life. This renewal process, bone remodeling, consists of the continuos removal of bone (bone resorption) followed by synthesis of new bone matrix and subsequent mineralization (bone formation).
E F, Eriksen, B, Langdahl
openaire +2 more sources
Bone scintigraphy in metabolic bone disease
Seminars in Nuclear Medicine, 1997The bone scan has well-recognized appearances in metabolic bone diseases, with its main clinical value found in focal conditions or the focal complications of disease. In clinical practice, the bone scan is most widely used to detect fractures in osteoporosis and pseudofractures in osteomalacia and to evaluate Paget's disease.
P J, Ryan, I, Fogelman
openaire +2 more sources

